VYST - Vystar Corporation
| Previous Close | 0.0100 |
| Open | 0.0100 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.0093 - 0.0100 |
| 52 Week Range | 0.0078 - 0.1580 |
| Volume | 2,724,812 |
| Avg. Volume | 2,638,210 |
| Market Cap | 10.762M |
| Beta (5Y Monthly) | 36.78 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0090 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire
Vystar Plans Dividend Spin Off of RxAir
WORCESTER, Mass., Oct. 16, 2019 -- Vystar Corp. (Vystar) (OTCQB Market: VYST) announced today that its Board of Directors has approved a plan to spin-off part of its RxAir air.
- GlobeNewswire
Vystar’s Securities to Begin Trading on OTCQB Sept. 10
Vystar Corp. (VYST) is approved to have its securities trade on the OTCQB marketplace, effective September 10, 2019. All classes of Vystar’s securities that were quoted on OTC Link® ATS as OTC Pink will be moved to OTCQB on Sept. 10. “Moving up to the OTCQB is a stepping stone for Vystar to move up to the OTCQX in the near future and then to a major exchange,” stated Steve Rotman, Vystar CEO.
- GlobeNewswire
Vystar Unveils Deproteinized Natural Rubber Latex As Platform for Sustainable Grades of Latex and Solid Rubbers at International Latex Conference
Creating Bioelastoplast natural rubber materials with improved performance for latex films and solid rubber dynamic applicationsIncorporating Single Walled Carbon Nano Tubes.
- GlobeNewswire
Brazil Issues Vystar Patent Notice of Allowance for Deproteinization of Vytex Natural Rubber Latex
Vystar Corp. (OTC Market: VYST) has received a notice of allowance from Brazil for a patent titled “Natural Rubber Latex Having Reduced Allergenicity and Method of Making Same” regarding a process to remove proteins, lipids and lutoids from natural rubber latex (NRL). Vystar now holds 12 international and four domestic patents related to its latex deproteinization process which results in Vytex®, a natural rubber latex virtually free of allergen-causing latex proteins, thereby reducing risk of developing or experiencing allergic reactions from direct contact.
- GlobeNewswire
Vystar Enters Definitive Agreement to Acquire Rotmans Furniture – Largest Independent Furniture Retailer in Northeast
Vystar Corp. (OTC Market: VYST), the creator of Vytex deproteinized natural rubber latex and developer of environmentally friendly technologies and products, announced today that it has signed a definitive agreement and has acquired Murida Furniture Company, D/B/A Rotmans Furniture and Carpet (“Rotmans”). Rotmans, the largest furniture and flooring store in New England and one of the largest independent furniture retailers in the U.S., encompassing 200,000 square feet in Worcester, Mass., and employing 150 people, was founded and has been under the leadership of the Rotman family for the past 50 years. In 2018, Rotmans had gross revenue of approximately $30 plus million. Vystar has acquired a controlling interest in Rotmans for $2,030,000, comprised of 25% cash over 4-8 years and 75% in notes convertible into shares. Vystar desires to uplist to NASDAQ and expects any conversion of the notes into shares to take place after that event.
- GlobeNewswire
Vystar Contracts Med Air Solutions to White Label ViraTech Air Purification Systems And Distribute to Medical Housing Markets, Nursing Homes and Ecuador
WORCESTER, Mass., June 10, 2019 -- Vystar® Corp. (OTC: VYST) and Competitive Edge Services LLC DBA Med Air Solutions (MAS) have signed an agreement whereby Med Air Solutions.
- GlobeNewswire
Vystar Contracts Rubber Expert Ranjit Matthan for Deproteinized Dry Rubber and Latex R&D
WORCESTER, Mass., June 03, 2019 -- Vystar Corp. (OTC Pink: VYST) extended and expanded its multi-year contract with Ranjit K. Matthan, Ph.D., an internationally renowned latex.
- GlobeNewswire
Vystar Acquires Fluid Energy Conversion Technology Assets, Expands Reach Into New Vertical Markets
Vystar plans to apply Fluid Energy Conversion (FEC) technology to increase pathogen killing efficiency, reduce size and cost of Vystar’s RxAir air purifiers. FEC technology expected to be used to negate viruses and bacteria using sound energy in a highly proprietary manner. Vystar plans to apply FEC technology to vape pens to improve substance delivery and control dosage.
- GlobeNewswire
Vystar Gains 1st Institutional Investor with $200K Investment at $0.15/Share
Vystar Corporation, (OTC Pink: VYST) a family of eco-friendly brands including Vytex® Natural Rubber Latex (NRL) and RxAir® air purification products, announced that FirstFire Global Opportunities Fund, LLC (FirstFire), an institutional investor who previously provided funding to Vystar, has invested $200,000 in Vystar at $0.15 per restricted common share, a 250 percent premium to yesterday’s market close. The stock purchase has no rights for conversion or warrants associated with it.
- GlobeNewswire
Vystar Retires PowerUp Convertible Note With Cash
Vystar Corporation, (OTC Pink: VYST) a family of eco-friendly brands including Vytex® Natural Rubber Latex (NRL) and RxAir® air purification products, announced that it has made payment of $142,000 including principal of $103,000, and interest of 12% and fees to retire the convertible promissory note held by PowerUp Lending Group, Ltd. (PowerUp) dated October 23, 2018. Since December of 2018, Vystar has paid off approximately $380,000 to PowerUp and has no additional notes with them.
- GlobeNewswire
Vystar Receives Second European Patent for Reduced Allergenicity Natural Rubber Latex
WORCESTER, Mass., March 04, 2019 (GLOBE NEWSWIRE) -- Vystar Corp. (OTC Market: VYST) has been granted European, EP Patent No. 2238183 entitled “Natural Rubber Latex Having Reduced Allergenicity and Method of Making Same.” Vystar now holds 13 foreign and 4 U.S. patents related to its latex deproteinization process for the production of Vytex®, a natural rubber latex (NRL) that is virtually free of allergen-causing latex proteins, thereby reducing risk of developing or experiencing allergic reactions to latex from direct contact. “This patent extends important intellectual property (IP) protection for Vystar in the production and distribution of Vytex to Europe using the Vytex formula to meet the growing demand for low protein NRL for products including balloons, examination and surgical gloves, condoms, breather bags, latex tubing, probe covers, catheters, threads, foams, cold seal and pressure sensitive adhesives,” stated Steve Rotman, CEO of Vystar.
- GlobeNewswire
Vystar to Resume Production of Rx3000 UV Light Air Purifiers for Use in Hospitals, Healthcare Facilities
Destroys on first pass more than 99.97% of harmful airborne viruses and bacteria. Inactivates pathogens that cause measles, the common cold, MRSA (staph), whooping cough, TB, pneumonia and other antibiotic-resistant and viral infections.
- GlobeNewswire
Vystar Debuts Enhanced RxAir® UV Light Air Purifiers to Fight Flu, Colds & Airborne Germs
Features longer-lasting, more effective UV light for more efficient inactivation of viruses and bacteriaRxAir available for medical, business and residentialRxAir now available.
- GlobeNewswire
Vystar® Begins Soft Launch of Vytex® Cloud Bed-in-a-Box via Rotmans
Sustainably sourced Vytex latex for ultra-long life, yet completely biodegradable. WORCESTER, Mass., Jan. 22, 2019 (GLOBE NEWSWIRE) -- Vystar® Corporation (VYST) today began the New England soft launch of Vytex® Cloud Bed-in-a-Box Collection of 100% all natural latex mattresses in three levels of support. The Bed-in-a-Box concept is a hit with consumers - transforming the $30 billion dollar a year mattress industry. Industry Bed-in-a-Box sales grew by 60% in 2017. In a society that is now comfortable with online sales and enjoys the convenience of to your door delivery, Bed-in-a-Box sales now account for nearly 30% of all mattress sales.